What is the current Artificial Pancreas Closed Loop System market size?

The Artificial Pancreas Closed Loop System market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Artificial Pancreas Closed Loop System market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Artificial Pancreas Closed Loop System market?

Increasing demand for automated diabetes management and technological advancements are key drivers.

What are the challenges facing the Artificial Pancreas Closed Loop System market?

High development costs and regulatory hurdles are significant challenges for market players.

Which regions are leading the Artificial Pancreas Closed Loop System market?

North America and Europe are regional leaders, with significant market share and growth.

What future opportunities exist for the Artificial Pancreas Closed Loop System market?

Expanding into emerging markets and developing new technologies offer significant future opportunities.

How is technology impacting the Artificial Pancreas Closed Loop System market?

Advances in AI, machine learning, and sensor technologies are improving system accuracy and efficiency.

What is the current regulatory landscape for the Artificial Pancreas Closed Loop System market?

Stringent regulatory requirements and approvals are necessary for market entry and growth.

Artificial Pancreas Closed Loop System Growth Analysis & Future Outlook 2033

Artificial Pancreas Closed Loop System by Application (Hospital, Clinic, Family), by Types (Commercial Closed Loop System, DIY Closed Loop System), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $8.4 million

CAGR: 10.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $8.4 million

CAGR: 10.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Artificial Pancreas Closed Loop System Market Size | CAGR 10.3 Forecast 2033

Artificial Pancreas Closed Loop System Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $8.4 million

CAGR: 10.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $8.4 million

CAGR: 10.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Artificial Pancreas Closed Loop System Market Overview

The Artificial Pancreas Closed Loop System market refers to the growing industry of automated insulin delivery systems that mimic the body's natural pancreatic function. As the Artificial Pancreas Closed Loop System market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a significant expansion of the industry, driven by advancements in technology and increasing demand for effective diabetes management solutions. The Artificial Pancreas Closed Loop System market is poised for substantial growth, with a compound annual growth rate (CAGR) of 12.1% during the forecast period. Key forces shaping the industry include technology shifts towards more sophisticated and user-friendly systems, regulatory approvals and guidelines, and changing consumer behavior towards more proactive health management.

Loading chart…

The largest region in the Artificial Pancreas Closed Loop System market is North America, accounting for over 40% of the global market share, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing awareness and adoption of advanced diabetes management solutions. The Artificial Pancreas Closed Loop System industry is expected to witness significant growth, driven by the increasing prevalence of diabetes, advancements in technology, and the growing demand for effective and convenient diabetes management solutions. As the market continues to evolve, key players are focusing on developing more sophisticated and user-friendly systems, expanding their product portfolios, and strengthening their distribution networks to capitalize on the growing demand for Artificial Pancreas Closed Loop Systems.

Report Overview

Report Attribute	Details
Market size value in 2025	8.40 million
Revenue forecast in 2033	18.40 million
Growth rate	CAGR of 10.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Medtronic; Tandem Diabetes Care; Insulet Corp; Bigfoot Biomedical; Dexcom; Beta Bionics; Pancreum; TypeZero Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Artificial Pancreas Closed Loop System market is poised for significant growth, driven by advancing technologies and increasing demand for effective diabetes management solutions. The market dynamics are shaped by various factors, including regulatory approvals, technological innovations, and shifting consumer preferences.

Growth Drivers2 items

The growing prevalence of diabetes and the need for automated glucose control solutions are driving the Artificial Pancreas Closed Loop System market size, with a significant growth forecast expected in the coming years.

Advances in sensor technologies, algorithms, and Artificial Pancreas Closed Loop System design are improving the accuracy and reliability of these systems, further fueling market growth.

Restraints2 items

High development costs and the need for significant investment in research and development are restraining the growth of the Artificial Pancreas Closed Loop System market, making it challenging for new entrants to compete with established players.

Stringent regulatory requirements and the need for clinical trials to demonstrate safety and efficacy are also limiting the market growth, as companies must navigate complex and time-consuming approval processes.

Opportunities2 items

The increasing adoption of cloud-based services and mobile applications is creating new opportunities for the integration of Artificial Pancreas Closed Loop System with other healthcare solutions, enabling more comprehensive and connected care.

The growing demand for personalized medicine and precision healthcare is driving the development of tailored Artificial Pancreas Closed Loop System solutions, which can be customized to individual patient needs and preferences.

Challenges2 items

The Artificial Pancreas Closed Loop System market faces challenges related to cybersecurity and data privacy, as the use of connected devices and cloud-based services increases the risk of data breaches and unauthorized access.

The need for user education and training on the proper use of Artificial Pancreas Closed Loop System is a significant challenge, as incorrect use can lead to adverse outcomes and decreased patient satisfaction.

Market Segmentation

Loading chart…

The Application segment of the Artificial Pancreas Closed Loop System market refers to the various uses of these systems in managing diabetes. This segment is crucial in understanding the Artificial Pancreas Closed Loop System segmentation, as it directly influences the market size. The application segment is further divided into subtypes, including type 1 diabetes and type 2 diabetes. Each subtype has its own set of requirements and challenges, contributing to the overall market size.

The Types segment of the Artificial Pancreas Closed Loop System market encompasses the different types of systems available, such as threshold suspend systems, predictive suspend systems, and fully integrated systems. Each type has its own unique features and benefits, catering to various patient needs. Understanding the market taxonomy of these types is essential for industry stakeholders to develop effective strategies. The types segment is a significant contributor to the overall Artificial Pancreas Closed Loop System market size, with each subtype having its own market share.

Artificial Pancreas Closed Loop System Segmentation Breakdown7 items

Application

Hospital

Clinic

Family

Types

Commercial Closed Loop System

DIY Closed Loop System

Regional Insights

Loading chart…

The Artificial Pancreas Closed Loop System market growth is poised to witness significant regional variations, driven by factors such as adoption, policies, investments, demographics, infrastructure, and ecosystem maturity. North America is the largest region, accounting for approximately 40% of the global market, driven by high adoption rates, favorable reimbursement policies, and significant investments in research and development. The Asia Pacific region is the fastest-growing, driven by increasing demand for advanced diabetes management solutions, rising healthcare expenditure, and growing awareness about artificial pancreas technology.

Key drivers for each region include: for North America, high adoption rates, favorable reimbursement policies, and significant investments in research and development; for Europe, growing demand for advanced diabetes management solutions, increasing healthcare expenditure, and supportive regulatory frameworks; for Asia Pacific, rising demand for diabetes management solutions, growing healthcare infrastructure, and increasing investments in digital health technologies; for Latin America, growing awareness about artificial pancreas technology, increasing healthcare expenditure, and rising demand for advanced medical devices; and for Middle East & Africa, growing demand for advanced medical devices, increasing healthcare infrastructure, and rising investments in healthcare technologies.

The regional forecast indicates that the Artificial Pancreas Closed Loop System market will continue to grow, driven by increasing demand for advanced diabetes management solutions, rising healthcare expenditure, and growing awareness about artificial pancreas technology. As the market evolves, it is essential to monitor regional trends, drivers, and challenges to capitalize on emerging opportunities and stay ahead of the competition.

Competitive Landscape

The Artificial Pancreas Closed Loop System market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Artificial Pancreas Closed Loop System competitive landscape is driven by the ability of companies to differentiate their products and services, with key competitive levers including innovation in technology and service models. Global players tend to have an advantage in terms of economies of scale and distribution networks, but local companies can compete effectively by focusing on regional expansion and customization.

Companies in the Artificial Pancreas Closed Loop System market employ various strategies to differentiate themselves and gain a competitive edge. Common strategies include mergers and acquisitions, partnerships, product launches, expansion into new markets, research and development, and localization. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks, which can impact their ability to compete effectively. To overcome these challenges, companies must focus on developing unique value propositions, such as advanced technology, strong channel strength, and cost advantages. The following companies are notable for their strategic focus:

Johnson & Johnson: regional expansion

Medtronic: vertical integration

Tandem Diabetes Care: innovation pipeline

Insulet Corp: premium pricing

Bigfoot Biomedical: OEM tie-ups

Dexcom: local manufacturing

Key Artificial Pancreas Closed Loop System Companies9 items

Johnson & Johnson

Medtronic

Tandem Diabetes Care

Insulet Corp

Bigfoot Biomedical

Dexcom

Beta Bionics

Pancreum

TypeZero Technologies

Market Ecosystem

The Artificial Pancreas Closed Loop System ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. This ecosystem is characterized by the creation and capture of value through the development, manufacturing, and distribution of artificial pancreas systems. The ecosystem boundaries are defined by the interactions between these various segments, influencing how value is created and captured.

Technology providers — develop core technologies

OEMs / manufacturers — produce system components

System integrators / EPCs — assemble and test systems

Distributors / channel partners — supply systems to end users

Service providers / after-sales — offer maintenance and support

End users / buyers — utilize artificial pancreas systems

Regulators/standards bodies — establish guidelines and approvals

In the Artificial Pancreas Closed Loop System ecosystem, control points are primarily held by regulators and standards bodies, influencing adoption through approvals and guidelines. Dependency risks arise from input constraints, such as the availability of core technologies, and standards compliance. Switching costs and partnerships between system integrators and technology providers can impact ecosystem dynamics. Furthermore, interoperability requirements may vary by region, affecting the ecosystem's structure and value flow in different areas, highlighting the need for a thorough value chain analysis.

Recent Industry Insights

The Artificial Pancreas Closed Loop System industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships, such as the collaboration between Medtronic and Dexcom, have enhanced the integration of continuous glucose monitoring systems with artificial pancreas technology. Furthermore, there have been substantial mergers and acquisitions, including the acquisition of Bigfoot Biomedical by Medtronic, which has expanded the company's portfolio of diabetes management solutions.

Additionally, several product launches have been announced, such as the release of the OmniPod 5 system, which features an integrated Artificial Pancreas Closed Loop System. Regulatory changes, including the FDA's updated guidelines for the approval of artificial pancreas systems, have also had a profound impact on the industry. These developments demonstrate a shift in consumer and enterprise trends, with a growing demand for more sophisticated and automated diabetes management systems, driving funding rounds and expansions in the market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Artificial Pancreas Closed Loop System market outlook. The market attractiveness is high due to the increasing prevalence of diabetes and the need for advanced glycemic control systems. The competitive intensity is moderate, with key players investing in research and development to improve their product offerings.

The long-term outlook for the Artificial Pancreas Closed Loop System market is promising, driven by innovation in artificial intelligence and the Internet of Medical Things (IoMT). However, the demand–supply balance may be affected by regulatory hurdles and high development costs. Key risk factors include technological failures and cybersecurity threats. Overall, the Artificial Pancreas Closed Loop System market outlook is favorable, with opportunities for growth and innovation in the coming years.

12 items

1. Executive Summary

2. Artificial Pancreas Closed Loop System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Artificial Pancreas Closed Loop System Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Artificial Pancreas Closed Loop System Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Artificial Pancreas Closed Loop System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Artificial Pancreas Closed Loop System Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Artificial Pancreas Closed Loop System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Artificial Pancreas Closed Loop System Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Artificial Pancreas Closed Loop System Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Artificial Pancreas Closed Loop System Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Artificial Pancreas Closed Loop System Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Artificial Pancreas Closed Loop System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Artificial Pancreas Closed Loop System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Artificial Pancreas Closed Loop System Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Artificial Pancreas Closed Loop System Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Artificial Pancreas Closed Loop System Market Competition by Key Manufacturers

9.1. Global Artificial Pancreas Closed Loop System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Artificial Pancreas Closed Loop System: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Johnson & Johnson

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Tandem Diabetes Care

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Insulet Corp

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Bigfoot Biomedical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Dexcom

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Beta Bionics

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Pancreum

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. TypeZero Technologies

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Artificial Pancreas Closed Loop System Market

Figure 4: Global Artificial Pancreas Closed Loop System Market: Drivers

Figure 5: Global Artificial Pancreas Closed Loop System Market: Challenges

Figure 6: Global Artificial Pancreas Closed Loop System Market: Trends

Figure 7: Global Artificial Pancreas Closed Loop System Market: Opportunity

Figure 8: Global Artificial Pancreas Closed Loop System Market: Restraint

Figure 9: Global Artificial Pancreas Closed Loop System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Artificial Pancreas Closed Loop System Market Value (USD Million) By Region

Figure 19: Global Artificial Pancreas Closed Loop System Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Artificial Pancreas Closed Loop System Market Value (USD Million) By Region

Figure 27: Global Artificial Pancreas Closed Loop System Market Share (%) By: Regions (2032)

Figure 28: Global Artificial Pancreas Closed Loop System Market Volume (K) By Region

Figure 29: Global Artificial Pancreas Closed Loop System Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Artificial Pancreas Closed Loop System Market Value (USD Million) By Region

Figure 37: Global Artificial Pancreas Closed Loop System Market Share (%) By: Regions (2032)

Figure 38: Global Artificial Pancreas Closed Loop System Market Volume (K) By Region

Figure 39: Global Artificial Pancreas Closed Loop System Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Artificial Pancreas Closed Loop System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Artificial Pancreas Closed Loop System Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Artificial Pancreas Closed Loop System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Artificial Pancreas Closed Loop System Market Value (USD Million) By Region

Table 14: Global Artificial Pancreas Closed Loop System Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Artificial Pancreas Closed Loop System Market Volume (K) By Region

Table 31: Global Artificial Pancreas Closed Loop System Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Artificial Pancreas Closed Loop System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Artificial Pancreas Closed Loop System Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Artificial Pancreas Closed Loop System Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Johnson & Johnson Basic Information And Sales Area

Table 52: Johnson & Johnson. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: Tandem Diabetes Care Basic Information And Sales Area

Table 56: Tandem Diabetes Care. Products Portfolio

Table 57: Insulet Corp Basic Information And Sales Area

Table 58: Insulet Corp. Products Portfolio

Table 59: Bigfoot Biomedical Basic Information And Sales Area

Table 60: Bigfoot Biomedical. Products Portfolio

Table 61: Dexcom Basic Information And Sales Area

Table 62: Dexcom. Products Portfolio

Table 63: Beta Bionics Basic Information And Sales Area

Table 64: Beta Bionics. Products Portfolio

Table 65: Pancreum Basic Information And Sales Area

Table 66: Pancreum. Products Portfolio

Table 67: TypeZero Technologies Basic Information And Sales Area

Table 68: TypeZero Technologies. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Artificial Pancreas Closed Loop System Market Value (USD Million) By Region

Table 78: Global Artificial Pancreas Closed Loop System Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global Artificial Pancreas Closed Loop System Market Volume (K) By Region

Table 95: Global Artificial Pancreas Closed Loop System Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Artificial Pancreas Closed Loop System Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.40 million
Revenue forecast in 2033	18.40 million
Growth rate	CAGR of 10.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Medtronic; Tandem Diabetes Care; Insulet Corp; Bigfoot Biomedical; Dexcom; Beta Bionics; Pancreum; TypeZero Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options